Accuray Incorporated
Accuray Incorporated (Nasdaq: ARAY) develops, manufactures, sells and supports radiation therapy systems and related treatment planning, imaging, motion-management and data-management software for hospitals and stand-alone treatment facilities. Its portfolio comprises the robotic CyberKnife platform and helical… From the company’s description.
Over the twelve months to Sep 30, 2026, Accuray Incorporated reported revenue of $394.53M, down 12.5% from a year earlier, and a net loss of $17.38M. Its operating margin was −13.1%, and operations used $22.97M in cash. In fiscal 2026, it reported revenue of $401.95M, down 12.3% from fiscal 2025, and a net loss of $49.19M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Accuray Incorporated does
In the company’s own words
Accuray Incorporated (Nasdaq: ARAY) develops, manufactures, sells and supports radiation therapy systems and related treatment planning, imaging, motion-management and data-management software for hospitals and stand-alone treatment facilities. Its portfolio comprises the robotic CyberKnife platform and helical systems, including Accuray Stellar, Radixact, Accuray Helix and Tomo C, alongside installation, training, maintenance and other professional services. These systems support treatments such as stereotactic radiosurgery, stereotactic body radiation therapy, intensity-modulated and image-guided radiation therapy, and adaptive radiotherapy for cancerous and benign tumors and selected neurologic or endocrine disorders. Accuray sells directly and through agents and group purchasing organizations in the United States, and through direct sales and distributors internationally; customers include radiation oncologists, neurosurgeons and other clinicians, as well as hospital administrators. Its China joint venture manufactures and sells the locally branded Tomo C system and distributes other Accuray systems. The company reports one operating segment. Accuray reported fiscal 2026 revenue of $[amount not provided] and manufactures its CyberKnife and TomoTherapy platforms in Wisconsin, with linear accelerators also produced in China. Its website is www.accuray.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- MADISON, WI
- Fiscal year end
- June
- CIK
- 1138723
- SIC
- 3841
Financial performance, year by year
Fiscal 2012–2026 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Accuray Incorporated — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Accuray Incorporated’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Accuray Incorporated and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Accuray Incorporated's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Accuray Incorporated's last four quarterly filings that the numbers alone won't show?”